227 related articles for article (PubMed ID: 12490575)
1. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.
Walker KM; Urban L; Medhurst SJ; Patel S; Panesar M; Fox AJ; McIntyre P
J Pharmacol Exp Ther; 2003 Jan; 304(1):56-62. PubMed ID: 12490575
[TBL] [Abstract][Full Text] [Related]
2. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain.
Pomonis JD; Harrison JE; Mark L; Bristol DR; Valenzano KJ; Walker K
J Pharmacol Exp Ther; 2003 Jul; 306(1):387-93. PubMed ID: 12721336
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice.
Rashid MH; Inoue M; Bakoshi S; Ueda H
J Pharmacol Exp Ther; 2003 Aug; 306(2):709-17. PubMed ID: 12724350
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
Gonzalez MI; Field MJ; Hughes J; Singh L
J Pharmacol Exp Ther; 2000 Aug; 294(2):444-50. PubMed ID: 10900217
[TBL] [Abstract][Full Text] [Related]
5. N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties.
Valenzano KJ; Grant ER; Wu G; Hachicha M; Schmid L; Tafesse L; Sun Q; Rotshteyn Y; Francis J; Limberis J; Malik S; Whittemore ER; Hodges D
J Pharmacol Exp Ther; 2003 Jul; 306(1):377-86. PubMed ID: 12721338
[TBL] [Abstract][Full Text] [Related]
6. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.
Seabrook GR; Sutton KG; Jarolimek W; Hollingworth GJ; Teague S; Webb J; Clark N; Boyce S; Kerby J; Ali Z; Chou M; Middleton R; Kaczorowski G; Jones AB
J Pharmacol Exp Ther; 2002 Dec; 303(3):1052-60. PubMed ID: 12438527
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain.
Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Maiorino M; Pietra C; Rondelli I; Chamiot-Clerc P; Simonato M; Barbieri M
J Pharmacol Exp Ther; 2003 Aug; 306(2):804-14. PubMed ID: 12750440
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia.
Pintér E; Helyes Z; Németh J; Pórszász R; Pethö G; Thán M; Kéri G; Horváth A; Jakab B; Szolcsányi J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):142-50. PubMed ID: 12122501
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of inflammation-induced thermal hypersensitivity by sumatriptan through activation of 5-HT(1B/1D) receptors.
Bingham S; Davey PT; Sammons M; Raval P; Overend P; Parsons AA
Exp Neurol; 2001 Jan; 167(1):65-73. PubMed ID: 11161594
[TBL] [Abstract][Full Text] [Related]
10. Relaxant effect of capsazepine in the isolated rat ileum.
Nocerino E; Izzo AA; Borrelli F; Capasso F; Capasso R; Pinto A; Sautebin L; Mascolo N
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):187-92. PubMed ID: 11882914
[TBL] [Abstract][Full Text] [Related]
11. Cloning and functional characterization of the guinea pig vanilloid receptor 1.
Savidge J; Davis C; Shah K; Colley S; Phillips E; Ranasinghe S; Winter J; Kotsonis P; Rang H; McIntyre P
Neuropharmacology; 2002 Sep; 43(3):450-6. PubMed ID: 12243775
[TBL] [Abstract][Full Text] [Related]
12. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists.
Appendino G; Harrison S; De Petrocellis L; Daddario N; Bianchi F; Schiano Moriello A; Trevisani M; Benvenuti F; Geppetti P; Di Marzo V
Br J Pharmacol; 2003 Aug; 139(8):1417-24. PubMed ID: 12922928
[TBL] [Abstract][Full Text] [Related]
13. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes.
Southall MD; Li T; Gharibova LS; Pei Y; Nicol GD; Travers JB
J Pharmacol Exp Ther; 2003 Jan; 304(1):217-22. PubMed ID: 12490594
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig.
Fox A; Gentry C; Patel S; Kesingland A; Bevan S
Pain; 2003 Sep; 105(1-2):355-62. PubMed ID: 14499454
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of thermal nociception and hyperalgesia by VR1 blockers.
García-Martinez C; Humet M; Planells-Cases R; Gomis A; Caprini M; Viana F; De La Pena E; Sanchez-Baeza F; Carbonell T; De Felipe C; Pérez-Paya E; Belmonte C; Messeguer A; Ferrer-Montiel A
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2374-9. PubMed ID: 11854530
[TBL] [Abstract][Full Text] [Related]
16. Functional vanilloid receptors in cultured normal human epidermal keratinocytes.
Inoue K; Koizumi S; Fuziwara S; Denda S; Inoue K; Denda M
Biochem Biophys Res Commun; 2002 Feb; 291(1):124-9. PubMed ID: 11829471
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological differences between the human and rat vanilloid receptor 1 (VR1).
McIntyre P; McLatchie LM; Chambers A; Phillips E; Clarke M; Savidge J; Toms C; Peacock M; Shah K; Winter J; Weerasakera N; Webb M; Rang HP; Bevan S; James IF
Br J Pharmacol; 2001 Mar; 132(5):1084-94. PubMed ID: 11226139
[TBL] [Abstract][Full Text] [Related]
18. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia.
Davis JB; Gray J; Gunthorpe MJ; Hatcher JP; Davey PT; Overend P; Harries MH; Latcham J; Clapham C; Atkinson K; Hughes SA; Rance K; Grau E; Harper AJ; Pugh PL; Rogers DC; Bingham S; Randall A; Sheardown SA
Nature; 2000 May; 405(6783):183-7. PubMed ID: 10821274
[TBL] [Abstract][Full Text] [Related]
19. Oral anti-hyperalgesic and anti-inflammatory activity of NK(1) receptor antagonists in models of inflammatory hyperalgesia of the guinea-pig.
Campbell EA; Gentry C; Patel S; Kidd B; Cruwys S; Fox AJ; Urban L
Pain; 2000 Sep; 87(3):253-263. PubMed ID: 10963905
[TBL] [Abstract][Full Text] [Related]
20. Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain.
Rashid MH; Inoue M; Kondo S; Kawashima T; Bakoshi S; Ueda H
J Pharmacol Exp Ther; 2003 Mar; 304(3):940-8. PubMed ID: 12604668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
